NEWS HIGHLIGHTSMedia Articles Related to Tramadol
62-Year-Old Man Becomes First Patient In China Implanted With Rechargeable Neurostimulator For Chronic Pain
Source: Health News from Medical News Today [2009.11.19]
St. Jude Medical, Inc. (NYSE:STJ) announced that a 62-year-old man from Shenzhen, Guangdong province has become the first patient in China to be implanted with the Eon™ neurostimulator, a rechargeable device used to help manage chronic pain. Despite prior back surgeries, the patient suffered from chronic back pain for more than a decade.
Common Pain Relief Medication May Encourage Cancer Growth
Source: Cancer / Oncology News From Medical News Today [2009.11.19]
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells. Two new studies advance that argument and demonstrate how shielding lung cancer cells from opiates reduces cell proliferation, invasion and migration in both cell-culture and mouse models.
CNSBio Inc. To Present Latest Clinical Trial Data For CNSB015 At Neuropathic Pain Conference In San Francisco
Source: Clinical Trials / Drug Trials News From Medical News Today [2009.11.19]
CNSBio Inc. will present recent Phase IIa proof-of-concept clinical trial data for CNSB015, an orally administered potassium channel modulator used in combination with opioids for the treatment of neuropathic pain, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain on November 20-21, 2009 in San Francisco, CA. Dr.
Transplanting People's Own Stem Cells Into Heart Lessens Pain, Improves Ability To Walk
Source: Clinical Trials / Drug Trials News From Medical News Today [2009.11.19]
The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in less pain and an improved ability to walk. The transplant subjects also experienced fewer deaths than those who didn't receive stem cells.
FDA Approves New Drug For Pain That Persists After Shingles
Source: Dermatology News From Medical News Today [2009.11.18]
The US Food and Drug Administration (FDA) announced yesterday that it has approved Qutenza (capsaicin) 8% patch for the treatment of post-herpetic neuralgia (PHN), an often excruciating pain that can persist for weeks, months and even years in 10 to 15 per cent of people who get shingles. The medicated skin patch, which is made by Lohmann Therapie-Systems AD of Andernach, Germany and distributed in the US by NeurogesX Inc.
Published Studies Related to Tramadol
Effects of tramadol on the minimum alveolar concentration of sevoflurane in dogs. [2009.07]
OBJECTIVE: To evaluate the effect of tramadol on sevoflurane minimum alveolar concentration (MAC(SEVO)) in dogs. It was hypothesized that tramadol would dose-dependently decrease MAC(SEVO).CONCLUSION AND CLINICAL RELEVANCE: Tramadol significantly reduced MAC(SEVO) but this was not dose dependent at the doses studied.
Pharmacokinetics of tramadol and its major metabolites following rectal and intravenous administration in dogs. [2009.06]
AIM: To compare the rectal and I/V administration of tramadol in dogs, to assess both its pharmacokinetic properties and absolute bioavailability... CONCLUSIONS: After rectal administration of tramadol suppositories, absorption of the active ingredient was rapid, but its metabolism quickly transformed the parent drug to high levels of M2 and M5. CLINICAL RELEVANCE: In the dog, rectal pharmaceutical formulation of tramadol would have a different pharmacokinetic behaviour than in humans.
Significance of the biopharmaceutical properties of tramadol sustained-release formulations for chrono-pharmacologically optimized treatment of pain from various sources. [2009.06]
Tramadol is currently one of the most frequently used opioid analgesics in the world. OBJECTIVE: The objective of this study was to investigate the rate and extent of tramadol bioavailability following evening versus morning intake of an extended-release pellet system designed for once daily administration. Moreover, the suitability of the preparation for chrono-adjusted pharmacotherapy was to be investigated... CONCLUSIONS: Bioavailability of the extended-release tramadol capsules for once daily administration is not affected by the time-point of administration. Total and maximum exposure of the product was bioequivalent after intake in the morning and at night. Thus, the time-point of administration may be adjusted to the patient's needs without any significant change in the in-vivo performance.
Comparison of analgesic effect of tramadol alone and a combination of tramadol and paracetamol in day-care laparoscopic surgery. [2009.06]
BACKGROUND AND OBJECTIVE: To compare the analgesic efficacy of tramadol alone (1.5 mg kg(-1)) with a tramadol (1 mg kg(-1)) and paracetamol combination in day-care laparoscopic patients... CONCLUSION: We conclude that reducing the dose of tramadol to 1 mg kg(-1) and combining it with paracetamol 1 g orally decreased the incidence of side effects of tramadol without reducing analgesic efficacy.
Analgesic efficacy of perioperative use of vedaprofen, tramadol or their combination in cats undergoing ovariohysterectomy. [2009.06]
The analgesic efficacy of tramadol and/or vedaprofen was evaluated in cats submitted for elective ovariohysterectomy, using a randomised double blind placebo controlled design. Forty adult female cats (3.0+/-0.32kg; 1.8+/-0.7 years) were distributed into four groups... This work also provides evidence for the benefits of analgesia for up to 3 days following ovariohysterectomy.
Clinical Trials Related to Tramadol
A Comparison of the Effectiveness and Safety of ULTRACETŪ (Tramadol Hydrochloride/Acetaminophen) Versus ULTRAMŪ (Tramadol Hydrochloride) Versus Placebo in Patients With Pain After Oral Surgery [Completed]
The purpose of this study is to explore the pain-relieving effects and safety of two
analgesic treatment regimens as compared to placebo in patients experiencing pain after oral
surgery. Tramadol hydrochloride/acetaminophen is approved to treat acute pain. This study
will evaluate the effectiveness and safety of tramadol hydrochloride/acetaminophen compared
with tramadol hydrochloride alone compared with placebo as a pain medication in the treatment
of pain following oral surgery.
Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain. [Completed]
This study investigates if Celebrex is as effective as tramadol hydrochloride (Ultram) for
patients with chronic low back pain, when administered over a 6-week period.
Comparison of Butorphanol and Tramadol Associated PCA After Hysterectomy [Completed]
Intravenous patient-controlled analgesia (PCA) is a popular technique for postoperative pain
management. Although several drugs are recognized as effective therapeutic options, optimal
selection of drugs in hysterectomy patients underwent different anesthesia treatments remains
unknown explicitly. We hypothesized that butorphanol and tramadol can produce different
analgesic effects with intravenous PCA after abdominal hysterectomy.
A One-Year, Open-Label Study to Assess the Safety and Effectiveness of Extended Release Tramadol HCl in the Treatment of Chronic, Non-Malignant Pain. [Completed]
The purpose of this study is to assess the safety of tramadol HCl ER following long-term
treatment. The study hypothesis is that long-term treatment with tramadol HCl ER is safe and
effective for the treatment of chronic, non-malignant pain.
A Study Comparing the Effectiveness and Safety of Extended Release Tramadol Versus Placebo for the Treatment of Osteoarthritis (OA) of the Knee [Completed]
The purpose of this study is to compare the analgesic effectiveness and safety of tramadol
HCl ER to placebo in patients with moderate to severe pain due to osteoarthritis (OA). The
study hypothesis is that tramadol HCl ER is effective and safe in the treatment of OA.
|
PATIENT REVIEWS / RATINGS / COMMENTSBased on a total of 15 ratings/reviews, Tramadol has an overall score of 5.27. The effectiveness score is 6.93 and the side effect score is 6.40. The scores are on ten point scale: 10 - best, 1 - worst. Below are selected reviews: the highest, the median and the lowest rated.
| | Tramadol review by 50 year old female patient | | | Rating |
| Overall rating: | |   |
| Effectiveness: | | Considerably Effective |
| Side effects: | | No Side Effects | | |
Treatment Info |
| Condition / reason: | | Pain |
| Dosage & duration: | | 50 mg every 6 hours or as needed taken twice daily for the period of 5 days |
| Other conditions: | | N/A |
| Other drugs taken: | | N/A | | |
Reported Results |
| Benefits: | | Pain relief allowing uninterupted sleep. |
| Side effects: | | None |
| Comments: | | Previous adverse effects from hydrocodone made Tramadol the drug of choice for pain relief after a complicated tooth extraction. I was very pleased to have adequate pain relief without the "fuzzy" feeling and slight nausea previously experienced with other prescription pain relievers. |
|
| | Tramadol review by 28 year old female patient | | | Rating |
| Overall rating: | | |
| Effectiveness: | | Moderately Effective |
| Side effects: | | No Side Effects | | |
Treatment Info |
| Condition / reason: | | Interstital Cystitis |
| Dosage & duration: | | 50mg taken 1 tablet every 6 hrs for the period of One month |
| Other conditions: | | Constant severe bladder pain |
| Other drugs taken: | | Ambien for a sleep disorder | | |
Reported Results |
| Benefits: | | The first two days I took this drug the pain went away. Then, the effectiveness declined rapidly. I called my doctor and she increased the dosage to 100mg every 6 hours. This helped for about two days, and then it was back to being ineffective.
I think this is a rather weak way to manage daily pain associated with IC. |
| Side effects: | | A little bit of nausea when the pill actually worked. No side effects at all when the pill didn't work. |
| Comments: | | My IC cocktail started to work after about a month and there wasn't much need for pain killers anymore so I just stopped taking Tramadol.
In the future, when my IC would flare up, I requested no Tramadol and instead received Tylenol with Codiene. It worked much better. |
|
| | Tramadol review by 26 year old female patient | | | Rating |
| Overall rating: | | |
| Effectiveness: | | Moderately Effective |
| Side effects: | | Extremely Severe Side Effects | | |
Treatment Info |
| Condition / reason: | | severe abdominal pain yet to be diagnosed |
| Dosage & duration: | | 50mg-100mg taken every 4 to 6 hours for the period of 2 weeks |
| Other conditions: | | insomnia and other GI issues |
| Other drugs taken: | | elavil for GI problems and metaprolol for mitral valve prolapse | | |
Reported Results |
| Benefits: | | The benefits were almost non-existent. I had taken this med before after a terrible car accident and therefore felt secure enough to take it again this time. However after only one day medicine stopped being effective. |
| Side effects: | | Some drowsiness at night after taken it throughout the day and some constipation. However after taking it for only two weeks I had a seizure that sent me to hospital and was told by doc there that elavil and tramadol combined can cause seizures! NO ONE told me this. Not my primary care doc, my GI doc or the pharmacist. This seems to me to be a pretty severe "side effect" for a medicine that barely works! The two meds were prescribed to me by the same physician and I understand oversights can happen. However if I had known from beginning that seizures might be a possibility I would asked for something else. Also after only two weeks I had some weird effects after stopping usage including diarrhea, cold sweats, hot flashes, restless leg syndrome and anxiety. I never experienced anything like this with any other meds. This medicine is NOT worth it! |
| Comments: | | 1 to 2 50mg tablets every 4 to 6 hours. |
|
|
